Applied Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Applied Therapeutics
APLT Stock  USD 0.10  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Applied Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Applied Therapeutics' valuation are summarized below:
Gross Profit
-38.1 M
Market Capitalization
14.9 M
Enterprise Value Revenue
5.418
Revenue
1000 K
Earnings Share
(0.10)
There are currently one hundred twenty fundamental signals for Applied Therapeutics that can be evaluated and compared over time across rivals. All traders should validate Applied Therapeutics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Applied Therapeutics Total Revenue

497,087

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 4.3 M, Interest Income of 4.3 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 248, Dividend Yield of 0.0 or PTB Ratio of 1.98. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Applied Stock
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Applied Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets61.4 M99.7 M37.1 M
Slightly volatile
Other Current Liabilities21.9 M25.6 M12.3 M
Slightly volatile
Total Current Liabilities27.4 M31.4 M15.6 M
Slightly volatile
Accounts Payable4.6 M5.1 M2.8 M
Slightly volatile
Cash95.9 M91.3 M29.9 M
Slightly volatile
Cash And Short Term Investments54.8 M91.3 M33.4 M
Slightly volatile
Common Stock Shares Outstanding168.5 M160.5 M43.1 M
Slightly volatile
Liabilities And Stockholders Equity61.4 M99.7 M37.1 M
Slightly volatile
Capital Surpluse293.2 M279.2 M111.4 M
Slightly volatile
Other Current Assets4.6 M4.9 M2.5 M
Slightly volatile
Total Liabilities29.3 M34.1 M19.3 M
Slightly volatile
Total Current Assets60 M96.2 M36.2 M
Slightly volatile
Short and Long Term Debt Total1.7 M2.5 M2.1 M
Very volatile
Property Plant And Equipment Net1.3 M2.5 M1.9 M
Slightly volatile
Current Deferred Revenue181.3 K190.8 K4.9 M
Pretty Stable
Capital Lease Obligations2.6 M2.5 M1.9 M
Very volatile
Property Plant And Equipment Gross1.3 M2.5 M1.9 M
Slightly volatile
Net Receivables318 K256.5 K441.1 K
Slightly volatile
Non Current Liabilities Other681.3 K683.1 K1.1 M
Slightly volatile

Applied Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income4.3 M4.1 M1.1 M
Slightly volatile
Depreciation And Amortization8559002.9 M
Slightly volatile
Selling General Administrative67 M63.8 M19.4 M
Slightly volatile
Other Operating Expenses72.3 M120.5 M44 M
Slightly volatile
Research Development45.4 M56.1 M26.9 M
Slightly volatile
Total Operating Expenses58.1 M64.4 M33.8 M
Slightly volatile
Reconciled Depreciation374.2 K489.9 K183.1 K
Slightly volatile
Selling And Marketing Expenses562.6 K631.4 K506.8 K
Slightly volatile

Applied Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation16.3 M15.5 M5.2 M
Slightly volatile
Begin Period Cash Flow30.1 M57.4 M18 M
Slightly volatile
Other Cashflows From Financing Activities6 M8.4 M7.1 M
Very volatile
Depreciation286.8 K488.8 K177.8 K
Slightly volatile
Total Cash From Financing Activities71 M130.9 M44.9 M
Slightly volatile
End Period Cash Flow95.9 M91.3 M29.9 M
Slightly volatile
Change To Netincome6.8 M12.4 M5 M
Slightly volatile
Issuance Of Capital Stock76.3 M120.5 M50.1 M
Slightly volatile
Cash And Cash Equivalents Changes30.9 M34.8 M37.9 M
Slightly volatile
Cash Flows Other Operating1.2 M1.4 M1.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio24823667.1995
Slightly volatile
Days Sales Outstanding8.339.3710.2263
Slightly volatile
Stock Based Compensation To Revenue27.9726.645.5599
Slightly volatile
EV To Sales47.0284.7932.5051
Slightly volatile
Inventory Turnover13.1414.7816.1301
Slightly volatile
Days Of Inventory On Hand17.7820.0121.8374
Slightly volatile
Payables Turnover8.419.93.5628
Slightly volatile
Sales General And Administrative To Revenue11511022.0569
Slightly volatile
Research And Ddevelopement To Revenue10196.4222.3711
Slightly volatile
Cash Per Share0.620.651.1024
Slightly volatile
Days Payables Outstanding36.2738.1782.8 K
Slightly volatile
Income Quality0.840.920.7706
Pretty Stable
Current Ratio3.333.523.1933
Pretty Stable
Receivables Turnover28.0531.5634.4446
Slightly volatile
Revenue Per Share0.00360.00380.0983
Slightly volatile
Interest Debt Per Share0.02190.0230.1204
Slightly volatile
Debt To Assets0.0350.03710.0378
Slightly volatile
Operating Cycle26.1129.3832.0637
Slightly volatile
Days Of Payables Outstanding36.2738.1782.8 K
Slightly volatile
Ebt Per Ebit0.90.911.0519
Pretty Stable
Long Term Debt To Capitalization0.080.09230.1006
Slightly volatile
Quick Ratio3.333.523.1906
Pretty Stable
Cash Ratio2.443.352.7419
Slightly volatile
Days Of Inventory Outstanding17.7820.0121.8374
Slightly volatile
Days Of Sales Outstanding8.339.3710.2263
Slightly volatile
Fixed Asset Turnover0.180.1918.4419
Slightly volatile
Debt Ratio0.0350.03710.0378
Slightly volatile
Price Sales Ratio24823667.1995
Slightly volatile
Asset Turnover0.00570.0060.1511
Slightly volatile

Applied Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap391.9 M263.5 M405.3 M
Slightly volatile
Enterprise Value333.4 M203.9 M350.8 M
Slightly volatile

Applied Fundamental Market Drivers

Applied Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue190.8 K181.3 K
Total Revenue523.2 K497.1 K
Cost Of Revenue56.1 M58.9 M
Stock Based Compensation To Revenue 26.64  27.97 
Sales General And Administrative To Revenue 109.70  115.19 
Research And Ddevelopement To Revenue 96.42  101.24 
Ebit Per Revenue(263.61)(250.43)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY